Trending

biosimilars

FDA releases Biosimilar Action Plan: Hear more at Biosimilars USA conference

FDA releases Biosimilar Action Plan: Hear more at Biosimilars USA conference

Biosimilars USA conference information

X

FDA releases Biosimilar Action Plan: Hear more at Biosimilars USA conference

https://pharmaphorum.com/partner-content/fda-releases-biosimilar-action-plan-hear-more-at-biosimilars-usa-conference/

FDA approves second Neupogen biosimilar

FDA approves second Neupogen biosimilar

Already facing competition from Sandoz, Amgen’s Neupogen white blood cell stimulator faces another cut-price near-copy after the FDA

X

FDA approves second Neupogen biosimilar

https://pharmaphorum.com/news/fda-approves-second-neupogen-biosimilar/

Biosimilar switches and healthcare gains

Biosimilar switches and healthcare gains

Despite being used across Europe for more than a decade, biosimilar medications are still something of a mystery

X

Biosimilar switches and healthcare gains

https://pharmaphorum.com/market-access-2/biosimilar-switches-and-healthcare-gains/

SMi’s Biosimilars & Biobetters Exclusive Interview with Dr Michel Mikhail released

SMi’s Biosimilars & Biobetters Exclusive Interview with Dr Michel Mikhail released

Biosimilars & Biobetters conference information

X

SMi’s Biosimilars & Biobetters Exclusive Interview with Dr Michel Mikhail released

https://pharmaphorum.com/partner-content/smis-biosimilars-biobetters-exclusive-interview-with-dr-michel-mikhail-released/

SMi’s 9th annual Biosimilars & Biobetters

SMi’s 9th annual Biosimilars & Biobetters

Biosimilars & Biobetters conference information

X

SMi’s 9th annual Biosimilars & Biobetters

https://pharmaphorum.com/events/smis-9th-annual-biosimilars-biobetters/

SMi’s 5th Annual Biosimilars USA Conference

SMi’s 5th Annual Biosimilars USA Conference

Biosimilars USA conference information

X

SMi’s 5th Annual Biosimilars USA Conference

https://pharmaphorum.com/events/smis-5th-annual-biosimilars-usa-conference/

Registration is open for the 9th Annual Biosimilars & Biobetters 2018 Event

Registration is open for the 9th Annual Biosimilars & Biobetters 2018 Event

Biosimilars & Biobetters conference information

X

Registration is open for the 9th Annual Biosimilars & Biobetters 2018 Event

https://pharmaphorum.com/partner-content/registration-is-open-for-the-9th-annual-biosimilars-biobetters-2018-event/

Agenda Released for USA Biosimilars Conference this November

Agenda Released for USA Biosimilars Conference this November

Agenda Released for USA Biosimilars Conference this Nov

X

Agenda Released for USA Biosimilars Conference this November

https://pharmaphorum.com/partner-content/agenda-released-for-usa-biosimilars-conference-this-november/

Amgen faces first Neulasta biosimilar rival as FDA approves Mylan drug

Amgen faces first Neulasta biosimilar rival as FDA approves Mylan drug

Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar

X

Amgen faces first Neulasta biosimilar rival as FDA approves Mylan drug

https://pharmaphorum.com/news/amgen-neulasta-biosimilar-fda-mylan-fulphila/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com